Molecular Diagnostic Yield of Chromosomal Microarray Analysis and Whole-Exome Sequencing in Children With Autism Spectrum Disorder.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Tammimies Kristiina, Marshall Christian R, Walker Susan, Kaur Gaganjot, Thiruvahindrapuram Bhooma, Lionel Anath C, Yuen Ryan K C, Uddin Mohammed, Roberts Wendy, Weksberg Rosanna, Woodbury-Smith Marc, Zwaigenbaum Lonnie, Anagnostou Evdokia, Wang Zhuozhi, Wei John, Howe Jennifer L, Gazzellone Matthew J, Lau Lynette, Sung Wilson W L, Whitten Kathy, Vardy Cathy, Crosbie Victoria, Tsang Brian, D'Abate Lia, Tong Winnie W L, Luscombe Sandra, Doyle Tyna, Carter Melissa T, Szatmari Peter, Stuckless Susan, Merico Daniele, Stavropoulos Dimitri J, Scherer Stephen W, Fernandez Bridget A
Аннотация
OBJECTIVE: To perform chromosomal microarray analysis (CMA) and whole-exome sequencing (WES) in a heterogeneous group of children with ASD to determine the molecular diagnostic yield of these tests in a sample typical of a developmental pediatric clinic.
DESIGN, SETTING, AND PARTICIPANTS: The sample consisted of 258 consecutively ascertained unrelated children with ASD who underwent detailed assessments to define morphology scores based on the presence of major congenital abnormalities and minor physical anomalies. The children were recruited between 2008 and 2013 in Newfoundland and Labrador, Canada. The probands were stratified into 3 groups of increasing morphological severity: essential, equivocal, and complex (scores of 0-3, 4-5, and ≥6).
EXPOSURES: All probands underwent CMA, with WES performed for 95 proband-parent trios.
MAIN OUTCOMES AND MEASURES: The overall molecular diagnostic yield for CMA and WES in a population-based ASD sample stratified in 3 phenotypic groups.
RESULTS: Of 258 probands, 24 (9.3%, 95%CI, 6.1%-13.5%) received a molecular diagnosis from CMA and 8 of 95 (8.4%, 95%CI, 3.7%-15.9%) from WES. The yields were statistically different between the morphological groups. Among the children who underwent both CMA and WES testing, the estimated proportion with an identifiable genetic etiology was 15.8% (95%CI, 9.1%-24.7%; 15/95 children). This included 2 children who received molecular diagnoses from both tests. The combined yield was significantly higher in the complex group when compared with the essential group (pairwise comparison, P = .002). [table: see text].
CONCLUSIONS AND RELEVANCE: Among a heterogeneous sample of children with ASD, the molecular diagnostic yields of CMA and WES were comparable, and the combined molecular diagnostic yield was higher in children with more complex morphological phenotypes in comparison with the children in the essential category. If replicated in additional populations, these findings may inform appropriate selection of molecular diagnostic testing for children affected by ASD.